|
|
|
|
Biotech Stock Alert for La Jolla Pharmaceutical Co. Issued by StockPreacher
DALLAS, Jan.14, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring drug company La Jolla Pharmaceutical Co. The report includes financial and investment analysis, analyst consensus, and pertinent industry information you...
|
|
|
Biotech Stock Alert for La Jolla Pharmaceutical Co. Issued by Sto...
Company: La Jolla Pharmaceutical Co.(LJPC) StockPreacher.com announces an investment report featuring drug company La Jolla Pharmaceutical Co. (Nasdaq:LJPC). The report includes financial and investment analysis, analyst consensus, and pertinent industry...
|
|
|
Biotech Stock Alert for La Jolla Pharmaceutical Co. Issued by StockPreacher
DALLAS, Jan.14, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring drug company La Jolla Pharmaceutical Co. The report includes financial and investment analysis, analyst consensus, and pertinent industry information you...
|
|
|
Biotech Stock Alert for La Jolla Pharmaceutical Co. Issued by StockPreacher
DALLAS, Jan.14, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring drug company La Jolla Pharmaceutical Co. (Nasdaq:LJPC). The report includes financial and investment analysis, analyst consensus, and pertinent industry...
|
|
|
Biotech Stock Alert for La Jolla Pharmaceutical Co. Issued by
DALLAS, Jan.14, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring drug company La Jolla Pharmaceutical Co. (Nasdaq:LJPC). The report includes financial and investment analysis, analyst consensus, and pertinent industry...
|
|
|
Biotech Stock Alert for La Jolla Pharmaceutical Co. Issued by StockPreacher
DALLAS, Jan.14, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring drug company La Jolla Pharmaceutical Co. The report includes financial and investment analysis, analyst consensus, and pertinent industry information you...
|
|
|
Biotech Stock Alert for La Jolla Pharmaceutical Co. Issued by StockPreacher
DALLAS, Jan.14, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring drug company La Jolla Pharmaceutical Co. (Nasdaq: LJPC). The report includes financial and investment analysis, analyst consensus, and pertinent industry...
|
|
|
Adrenal Venous Sampling for Catecholamines: A Normal Value Study
Freel EM et al.This report provides a reference range for adrenal vein catecholamine concentrations in nonpheochromocytoma patients and illustrates the wide variation in epinephrine and norepinephrine concentrations. Epinephrine and norepinephrine...
|
|
|
Sciele Introduces Adrenaclick? epinephrine injection, USP Auto-Injector for the Emergency Treatment of Ana
Sciele Pharma, Inc., a Shionogi company, announced the U.S.availability of Adrenaclick?, a single-dose, epinephrine auto-injector for the emergency treatment for severe allergic reactions (Type I) such as anaphylaxis. Adrenaclick? will be available as a...
|
|
|
Sciele Introduces Adrenaclick (epinephrine Injection, USP) Auto-Injector For The Emergency Treatment Of Anaphy
Sciele Pharma, Inc., a Shionogi company, today announced the U.S.availability of Adrenaclick, a single-dose, epinephrine auto-injector for the emergency treatment for severe allergic reactions (Type I) such as anaphylaxis. Adrenaclick will be available as...
|
|
|
Selective Mobilization of Cytotoxic Leukocytes by Epinephrine
Dimitrov S et al.Five cytotoxic effector leukocyte subsets comprise the marginal pool by a CD11a/CX3CR1mediated attachment to the endothelium. Selective Mobilization of Cytotoxic Leukocytes by Epinephrine.
|
|
|
Sciele Introduces Adrenaclick„ (epinephrine injection, USP) Auto-Injector for the Emergency Treatment
The single-dose, epinephrine auto-injector is now available in the United States ATLANTA--(BUSINESS WIRE)--Jan 7, 2010 - Sciele Pharma, Inc., a Shionogi company, today announced the U.S.availability of Adrenaclick, a single-dose, epinephrine auto-injector...
|
|
|
Sciele Introduces Adrenaclick (epinephrine injection, USP) Auto-Injector for the Emergency Treatment of Anaphylaxis
ATLANTA-- (BUSINESS WIRE) -- Sciele Pharma, Inc., a Shionogi company, today announced the U.S.availability of Adrenaclick, a single-dose, epinephrine auto-injector for the emergency treatment for severe allergic reactions (Type I) such as anaphylaxis.
|
|
|
Sciele Introduces Adrenaclick„ (epinephrine injection, USP) Auto-Injector for the Emergency Treatment
The single-dose, epinephrine auto-injector is now available in the United States Adrenaclick delivers epinephrine, the drug of choice for anaphylactic reactions, with the use of an auto-injector.The Adrenaclick auto-injector is designed to ensure accurate...
|
|
|
La Jolla Pharmaceutical Company Announces Signing of Definitive Merger Agreement With Adamis Pharmaceuticals
- La Jolla Pharmaceutical Company (NASDAQ: LJPC) (La Jolla) today announced that it entered into a definitive merger agreement with Adamis Pharmaceuticals Corporation (Adamis) (OTCBB: ADMP) on December 4, 2009.Upon closing, the combined company will focus on...
|
|
|
Adamis Pharmaceuticals Announces Signing of Definitive Merger Agreement
(OTCBB: ADMP), announced today that it has entered into a definitive merger agreement providing for the acquisition of La Jolla Pharmaceutical Company (NASDAQ: LJPC) by Adamis.The transaction was unanimously approved by the boards of directors of both...
|
|
|
Adamis Pharmaceuticals Announces Signing of Definitive Merger Agreement
SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporation (OTCBB: ADMP - News), announced today that it has entered into a definitive merger agreement providing for the acquisition of La Jolla Pharmaceutical Company (NASDAQ: LJPC - News) by Adamis.The...
|
|
|
Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in Nort
BRIDGEWATER, N.J., Nov.30 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today the signing of an exclusive licensing agreement with Intelliject, Inc. for a novel epinephrine auto injector for the emergency treatment of allergic reactions ...
|
|
|
Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in Nort
BRIDGEWATER, N.J., Nov.30 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today the signing of an exclusive licensing agreement with Intelliject, Inc. for a novel epinephrine auto injector for the emergency treatment of allergic reactions ...
|
